¸Þµð¾÷

´ëÇк´¿ø Çѹ溴¿ø
Á¾ÇÕº´¿ø ³ëÀκ´¿ø
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹Á¤º¸
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ëºÐ¾ç¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
¸ÞµðÅå
´ëÇк´¿ø Á¾ÇÕº´¿ø Çѹ溴¿ø Ä¡°úº´¿ø ÇÑÀÇ¿ø ³ëÀÎÀü¹®º´¿ø º¸°Ç¼Ò
¼­¿ï ºÎ»ê ÀÎõ ´ë±¸ ´ëÀü ±¤ÁÖ ¿ï»ê °æ±â °­¿ø ÃæºÏ Ãæ³² °æºÏ °æ³² ÀüºÏ Àü³² Á¦ÁÖ ¼¼Á¾
Ä¡°ú ¾È°ú ÇǺΰú ¼ºÇü¿Ü°ú »êºÎÀΰú ºñ´¢±â°ú ¿Ü°ú ³»°ú Á¤Çü¿Ü°ú À̺ñÀÎÈÄ°ú ¼Ò¾Æ°ú ¾à±¹

¸ñ·Ï ¼öÁ¤ »èÁ¦

2020 ´ëÇѽÅÀåÇÐȸ È£³²Áöȸ Ãß°è½ÉÆ÷Áö¾ö : 2020-09-03

ÃßõÇϱâ
¿¬¼ö°­Á À̹øÁÖ BEST
 
2020 ´ëÇѽÅÀåÇÐȸ È£³²Áöȸ Ãß°è½ÉÆ÷Áö¾ö : 2020-09-03
±³À°ÀÏÀÚ : 2020-09-03
±³À°Àå¼Ò : Àü³²´ëÇб³º´¿ø ¸íÇд밭´ç  
±³À°ÁÖÁ¦ : 2020 ´ëÇѽÅÀåÇÐȸ È£³²Áöȸ Ãß°è½ÉÆ÷Áö¾ö
ÁÖÃÖ±â°ü : ´ëÇѽÅÀåÇÐȸ
½ÃÇà±â°ü(ÁöºÎ/°ú) : È£³² Áöȸ  
´ã´çÀÚ : ±è⼺
¿¬¶ôó : 02-3486-8736  
À̸ÞÀÏ : laminion@hanmail.net      
±³À°Á¾·ù : ³»°ú      
Âü¼®¿¹»óÀοø : 60¸í
Èñ¸ÁÆòÁ¡ : 3Á¡  
Áö¿ª : ±¤ÁÖ±¤¿ª½Ã
±³À°½Ã°£ : 3 ½Ã°£ 0ºÐ  
¼¼ºÎ¼ö°­·á : 0¿ø      
ºñ°í       

±¸ºÐ ¿ùÀÏ °­ÀǽǠ½Ã°£ ±³À°Á¦¸ñ  °­»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±âŸ 09-03 ¸íÇд밭´ç 15:30~15:50 µî·Ï ¹× È£³²Áöȸ ȸÀå Àλ砠±è¼ö¿Ï(È£³²ÁöȸÀå) 
±âŸ 09-03 ¸íÇд밭´ç 15:50~16:00 ´ëÇѽÅÀåÇÐȸ ÀÌ»çÀå Àλ砠¾çö¿ì(´ëÇѽÅÀåÇÐȸ ÀÌ»çÀå) 
±³À°½Ã°£ 09-03 ¸íÇд밭´ç 16:00~16:25 A severe case of tenofovir-associated acute kidney injury requring hemodialysis in a patient with chronic B hepatitis  Á¶¾Æ¿µ(ÀüÁÖ¿¹¼öº´¿ø) 
±³À°½Ã°£ 09-03 ¸íÇд밭´ç 16:25~16:50 Xanthogranulomatous osteomyelitis of chest wall in a kidney transplantation patient  ÃÖÁ¾ÀÎ(Á¶¼±´ëÇб³º´¿ø) 
Åä·Ð 09-03 ¸íÇд밭´ç 16:50~17:00 ÆгÎÅäÀÇ(ÁÖÁ¦: Interesting cases of kidney disease)  À̽Ä(ÀüºÏ´ëÇб³º´¿ø) 
±³À°½Ã°£ 09-03 ¸íÇд밭´ç 17:00~17:25 ANCA associated vasculitides in a patient with positive serologic test for Hantan virus  ±èÇü¿Ï(ÀüºÏ´ëÇб³º´¿ø) 
±³À°½Ã°£ 09-03 ¸íÇд밭´ç 17:25~17:50 A 2-year study on the combination therapy of angiotensin II receptor blocker and midrine for proteinuria reduction in patients with hypotension or normal blood pressure  °­Èñ¸²(¿ø±¤´ëÇб³º´¿ø) 
Åä·Ð 09-03 ¸íÇд밭´ç 17:50~18:00 ÆгÎÅäÀÇ(ÁÖÁ¦: Hot issues of management of kideny disease)  ¸¶¼º±Ç(Àü³²´ëÇб³º´¿ø) 
±âŸ 09-03 ¸íÇд밭´ç 18:00~18:10 Coffee Break & Photo  () 
±³À°½Ã°£ 09-03 ¸íÇд밭´ç 18:10~18:35 Impact of obesity on the quality of life in patients with CKD  ¼­»óÇå(Àü³²´ëÇб³º´¿ø) 
±³À°½Ã°£ 09-03 ¸íÇд밭´ç 18:35~19:00 God committee  À̱¤¿µ(ÀüÁÖ¿¹¼öº´¿ø) 
Åä·Ð 09-03 ¸íÇд밭´ç 19:00~19:10 ÆгÎÅäÀÇ(ÁÖÁ¦: Emerging problems of ethical conflict)  ¾È¼±È£(¿ø±¤´ëÇб³º´¿ø) 
±âŸ 09-03 ¸íÇд밭´ç 19:10~19:20 Æóȸ  () 
ÆÄ¿ö¸µÅ© ±¤°íµî·Ï
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
¸Þµð¾÷
" 2020 ´ëÇѽÅÀåÇÐȸ È£³²Áöȸ Ãß°è½ÉÆ÷Áö¾ö : 2020-09-03""ÀÇ ÀÌ¿ëÈı⳪ Ãßõ´ñ±ÛÀ» ³²°Ü À¯¿ëÇÑ Á¤º¸·Î °øÀ¯ÇսôÙ. ^^
¡å
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
 
¸ñ·Ï ¼öÁ¤ »èÁ¦
ÀÌÀü±Û ÀºÆò±¸ÀÇ»çȸ Á¦2Â÷¿¬¼ö±³À°(Àü¸³¼±ºñ´ëÁõ, °ú¹Î¼º¹æ±¤) : 2020-09-03
´ÙÀ½±Û ÇѾç´ëÇб³º´¿ø À̺ñÀÎÈÄ°ú ¿Ü·¡¿¡¼­ ½ÃÇàÇÒ ¼ö ÀÖ´Â ºñ°ú °ü·Ã ÀçÈ° Ä¡·á : 2020-09-02
¹øÈ£ Á¦¸ñ Ãßõ Á¶È¸ µî·ÏÀÏ
20645 ´ë±¸ ´ëÇѾȰúÇÐȸ ´ë±¸°æºÏÁöȸ ¿¬¼ö±³À°-¹é³»Àå ¹× Àü¾ÈºÎ ÃֽŠÁö°ß : 2024-05-21 0 12 2024-05-10
20644 ¼­¿ï ¾çõ±¸ÀÇ»çȸ Ãá°è¿¬¼ö±³À°(Á¦2Çü ´ç´¢º´°ú ¸¸¼º ½ÅÀ庴, ÀÎÁöÀå¾Ö, ¸ÞŸ¹ö½º¿Í ÀÇ·á Çõ¸í) : 2024-05-21 0 21 2024-05-10
20643 ÃæºÏ 2024 Á¦Ãµ½ÃÀÇ»çȸ Ãá°è ¿¬¼ö°­Á : 2024-05-21 0 7 2024-05-10
20642 ºÎ»ê Á¦28Â÷ ¾Æ½Ã¾Æ-¿À¼¼¾Æ´Ï¾Æ »êºÎÀΰú¿¬¸Í Çмú´ëȸ (AOFOG 2024) (4ÀÏÂ÷) : 2024-05-20 0 26 2024-05-10
20641 ¼­¿ï ´ëÇÑÀÓ»ó³ëÀÎÀÇÇÐȸ 2024 Ãá°è ³ëÀÎÀÇÇÐ ¿¬¼ö°­Á : 2024-05-19 0 33 2024-05-10
20640 ¼­¿ï ´ëÇÑÀçÈ°ÀÇÇаúÀÇ»çȸ Stanley Lam ¿öÅ©¼¥ : 2024-05-19 0 38 2024-05-10
20639 ¼­¿ï Á¦40ȸ ´ëÇѳëÀÎÀÇÇÐȸ Ãá°èÇмú´ëȸ : 2024-05-19 0 30 2024-05-10
20638 ¼­¿ï ´ëÇÑÁ¾¾ç¿Ü°úÇÐȸ 2024³âµµ ¿¬¼ö°­Á : 2024-05-18 0 22 2024-05-10
20637 ÀÎõ 2024³âµµ Á¦47Â÷ ´ëÇѺ¹ºÎ¿µ»óÀÇÇÐȸ Çмú´ëȸ(2ÀÏÂ÷) : 2024-05-18 0 11 2024-05-10
20636 Àü³² 2024 Á¦2Â÷ ´ëÇѾȰúÀÇ»çȸ ½ÉÆ÷Áö¿ò : 2024-05-18 0 5 2024-05-10
20635 ¼­¿ï ´ëÇÑÇǺκ´¸®ÇÐȸ Á¦22ȸ ÇǺκ´¸® ½ÉÆ÷Áö¿ò : 2024-05-18 0 46 2024-05-10
20634 ´ëÀü 2024³â ´ëÀü±¤¿ª½ÃÀÇ»çȸ Ãá°èÇмú´ëȸ : 2024-05-18 0 24 2024-05-10
20633 ¼­¿ï ´ëÇѾȽŰæÀÇÇÐȸ Neurology of eye movements : 2024-05-18 0 39 2024-05-10
20632 ¼­¿ï ´ëÇÑÁ¾¾ç³»°úÇÐȸ KSMO Á¦ 22Â÷ Ãá°èÁ¤±â½ÉÆ÷Áö¾ö ¹× ÃÑȸ : 2024-05-17 0 10 2024-05-10
20631 ÀÎõ 2024³âµµ Á¦47Â÷ ´ëÇѺ¹ºÎ¿µ»óÀÇÇÐȸ Çмú´ëȸ(1ÀÏÂ÷) : 2024-05-17 0 8 2024-05-10
1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10
 
Ä¿¹Â´ÏƼ
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ë¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
º´¿øȨÆäÀÌÁö
¸ÞµðÅå
ÇÑÀÇ¿ø
¼ºÇü¿Ü°ú
Ä¡°ú
¾È°ú
¿©¼ºº´¿ø
³»°ú
Á¤Çü¿Ü°ú
ÇǺΰú
¼Ò¾Æ°ú
À̺ñÀÎÈÄ°ú
ºñ´¢ÀÇÇаú
¿ä¾çº´¿ø
ÀçÈ°ÀÇÇаú
µ¿¹°º´¿ø
±âŸº´ÀÇ¿ø
Ãë¾÷°ü·Ã
Áö¿ø¼­¾ç½Ä
¼­·ù¾ç½Ä
¸Þµð¾÷ ¸ð¹ÙÀÏÀ¥
¸Þµð¾÷